Therefore, we investigated the role of mRNA expression quantities of ERCC1, BRCA1, RRM1 and RRM2 in response to chemotherapy and clinical outcome of NSCLC patients. The gene discussed is BRCA1; the disease is non-small cell lung carcinoma.